Company Search:
Advanced Search
Sponsored Links
Nissui Pharmaceutical Co., Ltd. Company Snapshot
Nissui Pharmaceutical Co., Ltd. operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nissui Pharmaceutical Co., Ltd. with three other pharmaceutical manufacturers in Asia: Novartis India Limited of India (2016 sales of 8.08 billion Indian Rupees [US$121.17 million] of which 81% was Pharmaceuticals), Claris Lifesciences Ltd of India (7.54 billion Indian Rupees [US$113.06 million] ), and Dr. Lal PathLabs Ltd which is also based in India (7.91 billion Indian Rupees [US$118.62 million] ).

Sales Analysis. During the year ended March of 2016, sales at Nissui Pharmaceutical Co., Ltd. were ¥12.02 billion (US$115.71 million). This is a very small increase of 1.3% versus 2015, when the company's sales were ¥11.86 billion. Despite this increase, sales are still below the level achieved in 2014, when Nissui Pharmaceutical Co., Ltd. reported sales of ¥13.14 billion. The sales level in 2016 was fairly close to the level five years ago: in 2011, Nissui Pharmaceutical Co., Ltd. had sales of ¥13.28 billion. Sales of Industry Test Drug Business saw an increase that was more than double the company's growth rate: sales were up 3.3% in 2016, from ¥2.84 billion to ¥2.94 billion. Nissui Pharmaceutical Co., Ltd. also saw significant increases in sales in Clinical Diagnostics Business (up 1.8% to ¥5.17 billion) and Cosmetics (up 2.9% to ¥928.15 million) . Not all segments of Nissui Pharmaceutical Co., Ltd. experienced an increase in sales in 2016: sales of Pharmaceuticals fell 2.0% to ¥2.98 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Nissui Pharmaceutical Co., Ltd.
  Stock Performance Chart for Nissui Pharmaceutical Co., Ltd.
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 1,112.00
(Figures in Japanese Yen)
1 Week -2.6%   13 Weeks -4.7%  
4 Weeks -1.4%   52 Weeks -16.1%  
Nissui Pharmaceutical Co., Ltd. Key Data:
  Ticker: 4550 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 12,015,494,000
(Year Ending Jan 2017).
Employees: 328
  Currency: Japanese Yen Market Cap: 24,903,902,752
  Fiscal Yr Ends: March Shares Outstanding: 22,395,596
  Share Type: Common Closely Held Shares: 12,874,681
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.